Related Experiment Video
Updated: Jun 17, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Basic and clinical significance of IGF-I-induced signatures in cancer
1Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. hwerner@post.tau.ac.il
Abstract:
The insulin-like growth factor (IGF) system mediates growth, differentiation and developmental processes; it is also involved in various metabolic activities. Deregulation of IGF system expression and action is linked to diverse pathologies, ranging from growth deficits to cancer development. Targeting of the IGF axis emerged in recent years as a promising therapeutic approach in cancer and other medical conditions. Rational use of IGF-I-induced gene signatures may help to identify patients who might benefit from IGF axis-directed therapeutic modalities. In the accompanying research article in BMC Medicine, Rajski et al. show that IGF-I-induced gene expression in primary breast and lung fibroblasts accurately predict outcomes in breast and lung cancer patients.See the associated research paper by Rajski et al: http://www.biomedcentral.com/1741-7015/8/1.
Insights
Insulin-like growth factor (IGF) gene signatures in fibroblasts can predict patient outcomes in breast and lung cancers. This finding supports using IGF-I-induced gene expression to guide cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The insulin-like growth factor (IGF) system regulates crucial cellular processes including growth, differentiation, and metabolism.
- Aberrant IGF system activity is implicated in various diseases, notably cancer development and progression.
- Targeting the IGF axis is an emerging therapeutic strategy for cancer and other conditions.
Discussion:
- IGF-I-induced gene expression patterns in fibroblasts can serve as predictive biomarkers.
- This approach may help stratify patients for IGF axis-targeted therapies.
- The study highlights the utility of gene signatures in clinical decision-making.
Key Insights:
- IGF-I-induced gene signatures in primary breast and lung fibroblasts accurately predict patient outcomes in corresponding cancers.
- This provides a novel method for assessing prognosis in breast and lung cancer patients.
- The findings validate the potential of molecular signatures for personalized cancer treatment.
Outlook:
- Further research can explore the clinical application of IGF-I-induced gene signatures for patient stratification.
- This could lead to more effective and personalized therapeutic strategies in oncology.
- Investigating these signatures in other cancer types may broaden their applicability.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions
Some...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
